0001127602-24-016107.txt : 20240521
0001127602-24-016107.hdr.sgml : 20240521
20240521160303
ACCESSION NUMBER: 0001127602-24-016107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deschatelets Pascal
CENTRAL INDEX KEY: 0001657720
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 24969231
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-20
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657720
Deschatelets Pascal
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Chief Scientific Officer
0
Common Stock
2024-05-20
4
M
0
24500
3.76
A
1140483
D
Stock Option (Right to Buy)
3.76
2024-05-20
4
M
0
24500
0
D
2026-02-06
Common Stock
24500
12780
D
This stock option was granted on 02/08/2016 and is fully vested.
/s/ David Watson, attorney-in-fact for Pascal Deschatelets
2024-05-21